Loading…
Loading…
MSRM does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MSRM and 80,000+ other tickers.
See exactly how MSRM's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MSRM and 80,000+ other tickers.
Mushrooms, Inc. is a biotechnology company that develops products from mushrooms and mycelium. The company focuses on mycelium's industrial applications for carbon-neutral products, health supplements, and technologies for healthcare and textiles, such as bacterial detection and nutrient delivery. The company was formerly known as Marijuana Strategic Ventures Inc. and changed its name to Mushrooms Inc. in October 2022. [20, 22, 28, 33]
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to ten classes of mortgage-backed certificates from Morgan Stanley Residential Mortgage Loan Trust 2026-NEW2 (MSRM 2026-NEW2). MSRM 2026-NEW2 is an RMBS transaction sponsored by Morgan Stanley Mortgage Capital Holdings LLC as seller/sponsor and includes a meaningful concentration of collateral that KBRA considers to be “non-prime.” The $418.1 million RMBS transaction is collateralized by a pool of 670 fixed-rate residential mortgages.
Protein Matcha Expands the Brand's Dairy-Based Protein Offerings with an Instant Iced Drink Mix in Three Flavors That Also Includes Lion's Mane Mushroom for Focus and Coconut Water Powder and Sea Salt Electrolytes BOULDER, Colo., June 25, 2026 /PRNewswire/ -- Laird Superfood®, Inc. (NYSE American: LSF), a leader in functional coffee, creamers, and superfood products made with simple, minimally processed ingredients, today announced the launch of Protein Matcha, a new line of instant iced matcha latte mixes made with milk protein.
Early validation of mycelium-based infection detection and AI-powered MycoLab.ai platform strengthens commercialization outlook and strategic flexibility ESTERO, Fla., March 24, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Mushrooms Inc.
ESTERO, Fla., March 24, 2026 (GLOBE NEWSWIRE) -- Mushrooms Inc. (OTC: MSRM) today announced the successful early-stage validation of its mycelium-based infection detection technology and the completion of beta testing for its MycoLab.ai research platform, marking a significant advancement in the development of its MycoLabX platform.
Treatment-Resistant Depression (TRD) stands as one of the most stubborn and costly challenges in modern healthcare. For the millions of patients who have cycled through multiple antidepressants without relief, the treatment landscape has long been a graveyard of failed promises.